The TREAT-HEP Myanmar project delivers hepatitis C prevention testing and treatment services and hepatitis B testing and vaccination to people who inject drugs and their immediate family/partners through an established community-based clinic in Yangon, Myanmar.
Burnet Institute is collaborating with Myanmar Liver Foundation and other non-governmental organisations to co-design service interventions to ensure the delivery of an innovative and resilient community-based viral hepatitis clinic.
The project aims to:
2022–2025.
The TREAT-HEP project primarily delivers services to people who inject drugs and their partners/family at our established clinic in Yangon, Myanmar.
The project includes a service evaluation to monitor the services provided, through a prospective observational cohort.
In addition, the project utilises participatory action research methods through co-design workshops to design service delivery modifications to improve services provided, explore ways to increase sustainability and resilience of services, and provide tailored capacity building opportunities to local partner organisations.
The TREAT-HEP project provides services to people who inject drugs, including a needle and syringe program to contribute to preventing new hepatitis C infections, providing hepatitis B vaccination for prevention hepatitis B infections, and providing curative hepatitis C treatment for people who inject drugs in Yangon, Myanmar.
In addition, the project’s co-design model supports delivery of an effective model for community-based organisations to progress towards the goal of reducing viral hepatitis infections in Yangon, Myanmar.
Supported by the Australian Government through the Australian NGO Cooperation Program (ANCP)
Myanmar Liver Foundation (MLF)